Evidence map›Paper›PMID 33607232›Full record

ArticleBrain, behavior, and immunity2021

Therapeutic and prophylactic effects of macrophage-derived small extracellular vesicles in the attenuation of inflammatory pain.

Renée Jean-Toussaint, Zhucheng Lin, Yuzhen Tian, Richa Gupta, Richa Pande, Xuan Luo, Huijuan Hu, Ahmet Sacan, Seena K Ajit

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Pathology of pain and its implications for therapeutic interventions.Signal transduction and targeted therapy · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Renée Jean-ToussaintDepartment of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Zhucheng LinDepartment of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Yuzhen TianDepartment of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Richa GuptaDepartment of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Richa PandeDepartment of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA; Microbiology and Immunology Graduate Program, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Xuan LuoDepartment of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Huijuan HuDepartment of Anesthesiology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
Ahmet SacanSchool of Biomedical Engineering, Science & Health Systems, Drexel University, Philadelphia, PA 19104, USA.
Seena K AjitDepartment of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA. Electronic address: ska52@drexel.edu.
Drexel University · USRutgers, The State University of New Jersey · US

Funding

Exosome-mediated signaling in neuropathic painR01NS102836 · NINDS · DREXEL UNIVERSITY · PI AJIT, SEENA · 2017 to 2021
$1.9M
NINDS NIH HHS R01 NS102836
6 · The paper itself

Abstract

Small extracellular vesicles (sEVs) derived from antigen-presenting cells such as macrophages can induce therapeutically relevant immune responses. Anti-inflammatory miRNAs are elevated in sEVs secreted by RAW 264.7 mouse macrophages after lipopolysaccharide (LPS) stimulation. We observed uptake of these sEVs by primary mouse cortical neurons, microglia and astrocytes followed by downregulation of proinflammatory miRNA target genes in recipient cells. Pre-treating primary microglia with these sEVs decreased pro-inflammatory gene expression. A single intrathecal injection of sEVs derived from LPS stimulated RAW 264.7 cells attenuated mechanical hyperalgesia in the complete Freund's adjuvant (CFA) mouse model of inflammatory pain and formalin induced acute pain. Importantly, sEVs did not alter the normal pain threshold in control mice. RNA sequencing of dorsal horn of the spinal cord showed sEVs-induced modulation of immune regulatory pathways. Further, a single prophylactic intrathecal injection of sEVs two weeks prior, attenuated CFA-induced pain hypersensitivity and was ineffective in formalin model. This indicates that prophylactic sEVs administration can be beneficial in attenuating chronic pain without impacting responses to the protective physiological and acute inflammatory pain. Prophylactic administration of sEVs could form the basis for a safe and novel vaccine-like therapy for chronic pain or as an adjuvant, potentially reducing the dose of drugs needed for pain relief.

Indexed as

Extracellular VesiclesPainAnimalsHyperalgesiaInflammationMacrophagesMicePain ThresholdSpinal Cord

Identifiers

PMID33607232
PMCPMC8058272
OpenAlexW3130232165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.